Obeticholic acid: A new light in the shadows treating portal hypertension?

Authors

  • Jordi Gracia-Sancho Ph.D.,

    1. Barcelona Hepatic Hemodynamic Laboratory. Liver Unit. Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomédica en red de enfermedades hepáticas y digestivas (CIBERehd), Barcelona, Spain
    Search for more papers by this author
  • Virginia Hernández-Gea M.D., Ph.D.,

    1. Barcelona Hepatic Hemodynamic Laboratory. Liver Unit. Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomédica en red de enfermedades hepáticas y digestivas (CIBERehd), Barcelona, Spain
    Search for more papers by this author
  • Juan Carlos Garcia-Pagán M.D., Ph.D.

    Corresponding author
    1. Barcelona Hepatic Hemodynamic Laboratory. Liver Unit. Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomédica en red de enfermedades hepáticas y digestivas (CIBERehd), Barcelona, Spain
    • Address reprint requests to: Juan Carlos García-Pagán, M.D., Ph.D., Barcelona Hepatic Hemodynamic Unit, Liver Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomédica en red de enfermedades hepáticas y digestivas (CIBERehd), Barcelona, Spain. E-mail: jcgarcia@clinic.ub.es.

    Search for more papers by this author

  • Funded by a Ramón y Cajal contract from Ministerio de Economía and Competitividad (JG-S), the Instituto de Salud Carlos III (JG-S, JCG-P, and CIBERehd) and the Ministerio de Economía y Competitividad (JG-S and JCG-P).

  • See Article on Page 2286

  • Potential conflict of interest: Nothing to report.

No abstract is available for this article.

Ancillary